about
Pediatric Autoimmune Disorders Associated with Streptococcal Infections and Tourette's Syndrome in Preclinical Studies.The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment OptionsNonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosis.CSF-PR 2.0: An Interactive Literature Guide to Quantitative Cerebrospinal Fluid Mass Spectrometry Data from Neurodegenerative Disorders.Th1 and Th17 Cells and Associated Cytokines Discriminate among Clinically Isolated Syndrome and Multiple Sclerosis Phenotypes.Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosisVitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis.Changes in Blood B Cell-Activating Factor (BAFF) Levels in Multiple Sclerosis: A Sign of Treatment Outcome.Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNß in Multiple Sclerosis Patients According to the Therapeutic Response to IFNß.Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis.Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelinationNeurofilament light chain level is a weak risk factor for the development of MS.Metabolomic signatures associated with disease severity in multiple sclerosisNeuroproteomic profiling of human body fluids.Body fluid biomarkers for multiple sclerosis--the long road to clinical application.Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research.Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.Evidence of disease control: a realistic concept beyond NEDA in the treatment of multiple sclerosis.Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?Predictors of Response to Multiple Sclerosis Therapeutics in Individual Patients.Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study.Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis.(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis.Serum retinol levels are associated with brain volume loss in patients with multiple sclerosis.Autologous Bone Marrow Transplantation in Multiple Sclerosis: Biomarker Relevance for Patient Recruitment and Follow up.Optimizing multiple sclerosis diagnosis: gene expression and genomic association.Prevalence and predictors of blood-brain barrier damage in the HAART era.Composite Marker of Cognitive Dysfunction and Brain Atrophy is Highly Accurate in Discriminating Between Relapsing-Remitting and Secondary Progressive Multiple Sclerosis.Cross-reactivity of antibodies against interferon beta in multiple sclerosis patients and interference of the JAK-STAT signaling pathway.Vitamin D and Neurological Diseases: An Endocrine View.Biomarkers in the evolution of multiple sclerosis.The role of blood and CSF biomarkers in the evaluation of new treatments against multiple sclerosis.Fluid biomarker and electrophysiological outcome measures for progressive MS trials.The tension between early diagnosis and misdiagnosis of multiple sclerosis.Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis.Diagnostic methods used in searching for markers of atrophy in patients with multiple sclerosis.Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients.
P2860
Q26738436-D3A2A298-B197-4CE1-AA2D-609A438C8130Q28601505-06A9A9EA-281C-4F22-96F8-7429F4A21801Q30871249-3E34F059-E4DA-4915-9505-F2F37EEC3AEFQ31144959-9D7B9744-9733-40FB-A96E-4BFC24C5800FQ33855341-31E7397F-7393-4394-B666-2CE9CB82E8E8Q34524908-BEBEDECC-6358-498F-B91A-D543103E383EQ35653715-3675BD38-DFD3-4240-823A-45C9A9E6A639Q35850791-53CADD4B-A367-4F58-B9C3-83F0F803028DQ36253827-2F0FC04E-1D9D-449E-8FD6-A16B5F11033DQ36283207-D84FDB8D-BAC3-4AFE-B7F6-C06B008798D1Q36451661-E31BF550-83C9-4DA6-85BF-DE811DCD41CBQ37265143-41180501-0B8F-4964-B05D-C60CF96AE04EQ37613281-5F851FCE-2700-4D7A-BEC8-E4C23B84E25AQ38569255-A83296E9-E9FF-40C6-93EC-603240BB5746Q38590773-7F7A44DC-53EE-4ABF-B423-58ECEA511210Q38610689-1E00F565-EEA9-4B27-9D47-3FF3D8A6FB2DQ38682945-E419191A-3F3E-4487-9168-27398D94CF27Q38739510-5A224FC6-E144-4003-A03C-AA7A10A89D02Q38802998-FD30CEAA-88B5-4CCE-8C0C-F20F789C29EBQ38910574-9AC61500-3BE5-47AC-AE54-4430D3CB1A79Q38960854-7A1C7375-CC5C-40E2-A506-A0AB1075E541Q39025444-0EE04896-220E-48B5-954E-F77F5E1D3414Q39035274-C4ED7C7D-04C0-4318-A66D-4215D7D4618AQ39748242-82EBE5C6-6A81-47C7-B06E-81385457D23DQ40027938-E59F133C-3ED0-43E5-A4F2-47E86618BDD2Q40133625-B1AC8877-B265-460C-A6EF-AA5C445DAFE8Q41078810-E2256055-2FF2-406F-AD9C-470E2F67688FQ41236543-05DD857B-94BB-4956-9027-109AB645862FQ42201440-22091353-1098-439F-9741-85C7A4001588Q42208551-791740BB-B7D1-4CD4-94BE-0BF38E6DEB9BQ42322444-69FB26DD-A075-4189-9D26-6FF049FA4C68Q47159185-20A2F7FB-D0A0-44C5-B34C-A08F2B73DCD5Q47171978-F31E5523-5B3B-4261-8089-F4E1A19747D5Q47578484-5CF11029-D4C8-484F-999E-4587AC4D665CQ47579410-DAD6659A-178E-446F-998C-2A2AB544561FQ47638443-BB0DFF79-61E2-410B-A379-789AA9DB2747Q47800390-B208AADC-3677-4B08-A463-181D349AC9CDQ48217814-1D531AB2-BDD4-4F26-B81E-D4BBA74343FEQ49716124-7B5F3DA3-50A3-4FB7-B62F-BE3A49D4F7D7Q49957703-AFA49A11-0BCD-4588-A650-B7D7398AB7C6
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Body fluid biomarkers in multiple sclerosis
@ast
Body fluid biomarkers in multiple sclerosis
@en
Body fluid biomarkers in multiple sclerosis
@nl
type
label
Body fluid biomarkers in multiple sclerosis
@ast
Body fluid biomarkers in multiple sclerosis
@en
Body fluid biomarkers in multiple sclerosis
@nl
prefLabel
Body fluid biomarkers in multiple sclerosis
@ast
Body fluid biomarkers in multiple sclerosis
@en
Body fluid biomarkers in multiple sclerosis
@nl
P3181
P1433
P1476
Body fluid biomarkers in multiple sclerosis
@en
P2093
Manuel Comabella
P304
P3181
P356
10.1016/S1474-4422(13)70233-3
P407
P577
2014-01-01T00:00:00Z